Apart from these low-frequency genes, we included a set of known cancer genes (IDH1, IDH2, PTEN, TP53, NOTCH1, EGFR, CDKN2A, CDKN2B, NF1 and PIK3R1) for reference on our targeted resequencing effort. This evidence concerns the gene TP53 and cancer.